FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 34 filers reported holding FENNEC PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.35 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,506,186 | -14.9% | 466,869 | 0.0% | 2.56% | +10.9% |
| Q2 2023 | $4,122,453 | +6.1% | 466,869 | 0.0% | 2.31% | -10.0% |
| Q1 2023 | $3,884,350 | +27.7% | 466,869 | +47.3% | 2.57% | +5.3% |
| Q4 2022 | $3,042,710 | +98.0% | 316,949 | +67.0% | 2.44% | +198.8% |
| Q3 2022 | $1,537,000 | +45.1% | 189,750 | 0.0% | 0.82% | +58.4% |
| Q2 2022 | $1,059,000 | -0.4% | 189,750 | 0.0% | 0.52% | +15.5% |
| Q1 2022 | $1,063,000 | +27.3% | 189,750 | 0.0% | 0.45% | +112.4% |
| Q4 2021 | $835,000 | -49.3% | 189,750 | +8.6% | 0.21% | -64.0% |
| Q3 2021 | $1,646,000 | +86.8% | 174,750 | +44.6% | 0.58% | +18.7% |
| Q2 2021 | $881,000 | – | 120,851 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solas Capital Management, LLC | 849,979 | $3,400,000 | 3.47% |
| Southpoint Capital Advisors LP | 3,997,214 | $15,989,000 | 0.60% |
| Opaleye Management Inc. | 295,000 | $1,180,000 | 0.36% |
| 683 Capital Management, LLC | 971,351 | $3,885,000 | 0.35% |
| Avoro Capital Advisors LLC | 1,105,999 | $4,424,000 | 0.15% |
| Eventide Asset Management | 720,000 | $2,880,000 | 0.09% |
| Granahan Investment Management | 439,083 | $1,756,000 | 0.09% |
| Hartford Financial Management Inc. | 20,300 | $81,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 75,236 | $301,000 | 0.01% |
| Paloma Partners Management Co | 54,400 | $218,000 | 0.00% |